66703-1-Ig
antibody from Proteintech Group
Targeting: THRA
AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66703-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- THRA antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated THRA antibody (Cat. #66703-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A11C8
- Vial size
- 20ul, 150ul
Submitted references RNA-seq and ChIP-seq unveils thyroid hormone receptor α deficiency affects skeletal muscle myoblast proliferation and differentiation via Col6a1 during aging.
Exogenous thyroxine increases cardiac GLUT4 translocation in insulin resistant OLETF rats.
Thyroxine regulates pig Sertoli cell line proliferation and maturation through the IKK/NFκB and p38 MAPK signaling pathways.
A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.
Shi R, Chen G, Zhang Y, Zhang J, Yan L, Duan Y
Journal of muscle research and cell motility 2025 Sep;46(3):167-182
Journal of muscle research and cell motility 2025 Sep;46(3):167-182
Exogenous thyroxine increases cardiac GLUT4 translocation in insulin resistant OLETF rats.
Mendez DA, Soñanez-Organis JG, Yang X, Vazquez-Anaya G, Nishiyama A, Ortiz RM
Molecular and cellular endocrinology 2024 Sep 1;590:112254
Molecular and cellular endocrinology 2024 Sep 1;590:112254
Thyroxine regulates pig Sertoli cell line proliferation and maturation through the IKK/NFκB and p38 MAPK signaling pathways.
Li J, Zhang SX, Wang DL, Qi JJ, Bai CY, Sun H, Sun BX, Liang S
Theriogenology 2024 Oct 1;227:1-8
Theriogenology 2024 Oct 1;227:1-8
A NRF2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.
Wang W, Gao Y, Xu J, Zou T, Yang B, Hu S, Cheng X, Xia Y, Zheng Q
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Apr;11(14):e2307143
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Apr;11(14):e2307143
No comments: Submit comment
No validations: Submit validation data